ArticleFrontiers in oncology2026
Case Report: Rare presentations of glioblastoma: three multifocal and one cerebellar cases highlighting the value of shared clinical experience.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glioblastoma (GBM) is the most common and aggressive primary brain tumor in adults, typically presenting as a single supratentorial lesion. Multifocal/multicentric, and infratentorial variants are rare but clinically significant, often mimicking metastatic disease and limiting the feasibility of standard treatment. Their management remains challenging, and dedicated therapeutic guidelines are lacking. Methods: We describe four uncommon GBM presentations, three multifocal supratentorial tumors and one cerebellar tumor, and integrate their clinical trajectories with a review of the literature to highlight diagnostic and therapeutic considerations. Results: Across cases, diagnosis required comprehensive neuroimaging and, in several instances, exclusion of an extracranial primary malignancy. Molecular profiles were consistent with Conclusion: Rare presentations of GBM, including multifocal and cerebellar disease, carry substantial diagnostic ambiguity, limited therapeutic options, and a markedly poor prognosis. Early multidisciplinary evaluation, optimized supportive care, and research focused on tailored treatment strategies are urgently needed to improve outcomes in these challenging GBM subtypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.